Testing a tool to help pick HIV medications
Part of Immune system & allergy, Infections clinical trials.
This study tests a clinical decision support tool that helps doctors choose the best antiretroviral therapy for people with HIV based on drug resistance testing results. It may help optimize treatment for patients and improve how providers make decisions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have HIV-1 infection confirmed by a doctor.
- You must be at least 18 years old.
- You must have had a resistance test done or scheduled through your regular care.
- You must be able to give informed consent (understand and agree to participate).
- If you are a provider, you must agree to participate in the study and use the tool.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a special pill that has a sensor inside, which sends information to your doctor or care team to help you remember to take your HIV medication. It is for people who sometimes miss doses and want extra support.
This study tests a new approach to help men at risk for HIV stay healthy by providing access to PrEP through a mobile app. The goal is to see if the program helps men start and stay on PrEP compared to standard care.
This study is testing a program to help people with HIV stick with their medication. It looks at how well doctors and patients work together to make treatment decisions and improve health outcomes.
This trial tests a decision support tool that helps emergency department patients learn about PrEP (a daily pill that prevents HIV). It is for people who are HIV negative and not already taking HIV prevention medicine.
This study tests a simple online tool to help young people decide whether PrEP (a daily pill that prevents HIV) might be right for them. The tool uses information from an at-home HIV test and is designed to make PrEP information easier to understand.
This study is testing a tool to find people who may be at risk for or already have HIV or hepatitis C. It aims to connect them with care and support.
Hear when a new HIV (Human Immunodeficiency Virus) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.